carbostyril has been researched along with Chlamydia Infections in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 12 (63.16) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Barbee, LA; Dombrowski, JC; Golden, MR; Jensen, JS; Khosropour, CM; Leipertz, G; Manhart, LE; Pascual, R; Soge, OO; Unutzer, A | 1 |
| Chen, YH; Hsueh, PR; Huang, CH; Lai, CC | 1 |
| Cevenini, R; Donati, M; Fortugno, MT; Laghi, E; Pollini, GM; Sparacino, M | 1 |
| Hammerschlag, MR; Roblin, PM | 2 |
| Greub, G; Hammerschlag, MR; Senn, L | 1 |
| Manavi, K | 1 |
| Hattori, H; Nakamura, S; Nakata, K; Okazaki, Y | 1 |
| Campbell, LA; Cosgrove, YT; Kuo, CC; Patton, DL | 1 |
| Barlow, D; Dimian, C; Moi, H; Perea, E; Phillips, I; Stolz, E; Weidner, W | 1 |
| Kishimoto, T; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y | 1 |
| Butaye, P; De Backer, P; Ducatelle, R; Haesebrouck, F; Remon, JP; Vermeersch, H | 1 |
| Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D | 1 |
| Hook, EW; Jones, RB; Martin, DH; McCormack, WM | 1 |
| Arakawa, S; Fujii, A; Kamidono, S; Maeda, H; Nakata, K; Umezu, K | 1 |
| Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G; Winkler, I | 1 |
| Gohro, T; Hayashi, K; Henmi, I; Kato, S; Kumamoto, Y; Sakai, S; Tabata, S; Tanda, H; Tsunekawa, T; Yoshio, H | 1 |
| Abe, K; Gohro, T; Hayashi, K; Hirose, T; Kodama, N; Kumamoto, Y; Miyagishi, T; Mohri, K; Ueno, T | 1 |
| Oriel, JD | 1 |
4 review(s) available for carbostyril and Chlamydia Infections
| Article | Year |
|---|---|
The potential role of nemonoxacin for treatment of common infections.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Clostridium Infections; Community-Acquired Infections; Drug Therapy, Combination; Gonorrhea; Humans; Levofloxacin; Pneumonia, Bacterial; Quinolones; Skin Diseases, Bacterial | 2015 |
Therapeutic approaches to Chlamydia infections.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Conjunctivitis, Inclusion; Female Urogenital Diseases; Humans; Macrolides; Pneumonia, Bacterial; Practice Guidelines as Topic; Quinolones; Randomized Controlled Trials as Topic; Tetracyclines; Trachoma | 2005 |
A review on infection with Chlamydia trachomatis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Conjunctival Diseases; Contact Tracing; Female; Genital Diseases, Male; Humans; Lymphogranuloma Venereum; Macrolides; Male; Mass Screening; Pelvic Inflammatory Disease; Penicillins; Quinolones; Tetracyclines; United Kingdom | 2006 |
Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis.
Topics: 4-Quinolones; Anti-Infective Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Gonorrhea; Humans; Norfloxacin; Quinolines; Quinolones; Urethritis | 1986 |
5 trial(s) available for carbostyril and Chlamydia Infections
| Article | Year |
|---|---|
A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Double-Blind Method; Doxycycline; Drug Administration Schedule; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Ureaplasma Infections; Ureaplasma urealyticum; Urethritis | 1996 |
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome | 1998 |
Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Double-Blind Method; Doxycycline; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Middle Aged; Piperazines; Quinolones; Treatment Outcome; Uterine Cervicitis | 1998 |
[Epidemiological and therapeutic study on gonorrheal infection--study on NY-198 (lomefloxacin) single administration therapy. Sapporo Clinical Research Group for STD].
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Resistance, Microbial; Female; Fluoroquinolones; Gonorrhea; Humans; Japan; Male; Middle Aged; Neisseria gonorrhoeae; Quinolones; Urethritis; Uterine Cervicitis | 1990 |
[Epidemiological and therapeutic study on urethritis of male and cervicitis from viewpoint of STD--a study using NY-198. Sapporo Clinical Research Group for STD].
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Resistance, Microbial; Female; Fluoroquinolones; Gonorrhea; Humans; Japan; Male; Middle Aged; Neisseria gonorrhoeae; Quinolones; Sexually Transmitted Diseases; Urethritis; Uterine Cervicitis | 1990 |
10 other study(ies) available for carbostyril and Chlamydia Infections
| Article | Year |
|---|---|
High Prevalence of Vaginal and Rectal Mycoplasma genitalium Macrolide Resistance Among Female Sexually Transmitted Disease Clinic Patients in Seattle, Washington.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Coinfection; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Macrolides; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Nucleic Acid Amplification Techniques; Prevalence; Quinolones; Rectum; Retrospective Studies; Vagina; Washington | 2020 |
Comparative in vitro activity of garenoxacin against Chlamydia spp.
Topics: Animals; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Chlamydophila psittaci; Fluoroquinolones; Humans; Indoles; Macrolides; Microbial Sensitivity Tests; Quinolones; Tetracyclines | 2002 |
The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Chlamydophila pneumoniae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 2004 |
Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.
Topics: Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Female; Fluoroquinolones; Leukopenia; Lung; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones | 1994 |
Effects of quinolone analog CI-960 in a monkey model of Chlamydia trachomatis salpingitis.
Topics: Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; DNA Probes; Fallopian Tubes; Female; Fluoroquinolones; Immunoenzyme Techniques; In Situ Hybridization; Macaca nemestrina; Quinolones; Salpingitis | 1993 |
In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.
Topics: Animals; Anti-Infective Agents; Chlamydia; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Chlamydophila psittaci; Disease Models, Animal; Fluoroquinolones; Gatifloxacin; Male; Mice; Microbial Sensitivity Tests; Piperazines; Pneumonia, Bacterial; Quinolones | 1997 |
In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydophila psittaci; Chlorocebus aethiops; Doxycycline; Enrofloxacin; Europe; Fluoroquinolones; Microbial Sensitivity Tests; Poultry Diseases; Quinolones; Turkeys | 1997 |
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydophila pneumoniae; Doxycycline; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 1998 |
In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Quinolones; Tetracyclines | 1992 |
Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases.
Topics: Cefpirome; Cephalosporins; Chancroid; Chlamydia; Chlamydia Infections; Gardnerella vaginalis; Gonorrhea; Haemophilus ducreyi; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quinolones; Sexually Transmitted Diseases, Bacterial | 1992 |